litlas
Log inCreate account

David L. DeMets

Active 1972–2025

Also published as
David L DeMets
94
Papers
53,350
Citations
76
h-index
91
i10-index

Citations

Citations per year for David L. DeMets1970: 1 citations1971: 1 citations1976: 1 citations1977: 6 citations1978: 2 citations1979: 6 citations1980: 4 citations1981: 7 citations1982: 7 citations1983: 9 citations1984: 20 citations1985: 13 citations1986: 23 citations1987: 17 citations1988: 24 citations1989: 30 citations1990: 26 citations1991: 41 citations1992: 37 citations1993: 60 citations1994: 70 citations1995: 77 citations1996: 63 citations1997: 87 citations1998: 136 citations1999: 124 citations2000: 126 citations2001: 138 citations2002: 198 citations2003: 199 citations2004: 198 citations2005: 278 citations2006: 272 citations2007: 242 citations2008: 230 citations2009: 251 citations2010: 238 citations2011: 193 citations2012: 235 citations2013: 242 citations2014: 253 citations2015: 254 citations2016: 237 citations2017: 259 citations2018: 214 citations2019: 904 citations2020: 1,347 citations2021: 1,433 citations2022: 1,248 citations2023: 1,087 citations2024: 1,724 citations2025: 897 citations2026: 34 citations1972–1975: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,633 citing papers, 23.1% of this breakdownUnited Kingdom: 2,227 citing papers, 9.1% of this breakdownCanada: 1,317 citing papers, 5.4% of this breakdownItaly: 1,288 citing papers, 5.3% of this breakdownGermany: 1,218 citing papers, 5% of this breakdownChina: 923 citing papers, 3.8% of this breakdownNetherlands: 908 citing papers, 3.7% of this breakdownFrance: 835 citing papers, 3.4% of this breakdownAustralia: 731 citing papers, 3% of this breakdownSweden: 679 citing papers, 2.8% of this breakdownJapan: 632 citing papers, 2.6% of this breakdownDenmark: 620 citing papers, 2.6% of this breakdown
0%23.1%Other 30.2%

Institutions

Fields

  • Medicine82.9%
  • Biochemistry, Genetics and Molecular Biology6.6%
  • Mathematics2.2%
  • Neuroscience1.1%
  • Economics, Econometrics and Finance0.9%
  • Immunology and Microbiology0.8%
  • Other5.5%

Topics

  • Diabetes Treatment and Management8.3%
  • Heart Failure Treatment and Management7.3%
  • Cardiovascular Function and Risk Factors5.7%
  • Cardiac pacing and defibrillation studies3.9%
  • Pancreatic function and diabetes2.1%
  • Cardiac electrophysiology and arrhythmias1.9%
  • Other70.8%

Coauthors

All papers

Open in search
  1. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction

    Authors: John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Inder S. Anand, Jan Bělohlávek, Michael Böhm, Chern‐En Chiang, Vijay Chopra, Rudolf A. de Boer, Akshay S. Desai, Mirta Díez, Jarosław Dróżdż, Andrej Dukát, Junbo Ge, Jonathan G. Howlett, Tzvetana Katova, Masafumi Kitakaze, Charlotta Ljungman, Béla Merkely, José Carlos Nicolau, Eileen O’Meara, Mark C. Petrie, Pham Nguyễn Vinh, Morten Schou, С. Н. Терещенко, Subodh Verma, Claes Held, David L. DeMets, Kieran F. Docherty, Pardeep S. Jhund, Olof Bengtsson, Mikaela Sjöstrand, Anna-Maria Langkilde - New England Journal of Medicine 2019 cited by 6,873

  2. Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

    Authors: Scott D. Solomon, John J.V. McMurray, Brian Claggett, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Akshay S. Desai, Pardeep S. Jhund, Jan Bělohlávek, Chern‐En Chiang, C. Jan Willem Borleffs, Josep Comín‐Colet, Dan Dobreanu, Jarosław Dróżdż, James C. Fang, Marco A. Alcocer‐Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan Janssens, Tzvetana Katova, Masafumi Kitakaze, Béla Merkely, Eileen O’Meara, José Francisco Kerr Saraiva, С. Н. Терещенко, Jorge Thierer, Muthiah Vaduganathan, Orly Vardeny, Subodh Verma, Vinh Pham, Ulrica Wilderäng, Natalia Zaozerska, Erasmus Bachus, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde - New England Journal of Medicine 2022 cited by 2,658

  3. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Authors: Adrian F. Hernandez, Jennifer B. Green, Salim Janmohamed, Ralph B. D’Agostino, Christopher B. Granger, Nigel C. Jones, Lawrence A. Leiter, Anne E Rosenberg, Kristina N. Sigmon, Matthew C. Somerville, Karl M. Thorpe, John J.V. McMurray, Stefano Del Prato, Stefano Del Prato, John J.V. McMurray, Ralph B. D’Agostino, Christopher B. Granger, Adrian F. Hernandez, Salim Janmohamed, Lawrence A. Leiter, Robert M. Califf, Rury R. Holman, David L. DeMets, Matthew C. Riddle, Shaun G. Goodman, Darren K. McGuire, Karen Alexander, Adam D. DeVore, Chiara Melloni, Chetan B. Patel, David C. M. Kong, Gerald S. Bloomfield, Matthew T. Roe, Pierluigi Tricoci, Robert W. Harrison, Renato D. Lópes, Robin Mathews, Rajendra Mehta, W. Schuyler Jones, Sreekanth Vemulapalli, Thomas J. Povsic, Zubin J. Eapen, Keith Dombrowski, Brad J. Kolls, J. Dedrick Jordan, Andrew P. Ambrosy, Stephen J. Greene, Aditya Mandawat, Jay Shavadia, Lauren B. Cooper, Abhinav Sharma, Patrícia O. Guimarães, Daniel J. Friedman, Matthew E. Wilson, Patricia Endsley, Tracy Gentry, Jeannie Collier, Kathleen Perez, K.E. James, Jennifer Roush, C. ARDEN III POPE, Christina Howell, Megan Johnson, M. Bailey, Joanna Cole, Teresa Akers, Beth Vandyne, Betsy Thomas, Jenny Rich, Susan Bartone, Gail Beaulieu, Kim Brown, Tuan Chau, Tamra Christian, Rebecca Coker, Deb Greene, Trevorlyn Haddock, Wendy Jenkins, Ghazala Haque, Marsha L. Marquess, Jean Pesarchick, Renee Rethaford, Allegra Stone, Firas Al- Kawas, Michelle A. Anderson, Robert Enns, Isaac Sinay, Chantal Mathieu, Victor Yordanov, Irene Hramiak, Martin Haluzı́k, Søren Galatius, Bruno Guerci, Michael A. Nauck, Ilias Migdalis, Choon Beng Kathryn Tan, Győző Kocsis, Andrea Giaccari, Moon Kyu Lee, Ernesto Muñoz and 708 more - The Lancet 2018 cited by 1,791

  4. Interpretation of the evidence for the efficacy and safety of statin therapy

    Authors: Rory Collins, Christina Reith, Jonathan Emberson, Jane Armitage, Colin Baigent, Lisa Blackwell, Roger S. Blumenthal, John Danesh, George Davey Smith, David L. DeMets, Stephen Evans, Malcolm Law, Stephen MacMahon, Seth S. Martin, Bruce Neal, Neil R Poulter, David Preiss, Paul M. Ridker, Ian Roberts, Anthony Rodgers, Peter Sandercock, Kenneth F. Schulz, Peter Sever, John Simes, Liam Smeeth, Nicholas Wald, Salim Yusuf, Richard Peto - The Lancet 2016 cited by 1,844

  5. Dapagliflozin across the range of ejection fraction in patients with heart failure: a patient-level, pooled meta-analysis of DAPA-HF and DELIVER

    Authors: Pardeep S. Jhund, Toru Kondo, Jawad H. Butt, Kieran F. Docherty, Brian Claggett, Akshay S. Desai, Muthiah Vaduganathan, Samvel B. Gasparyan, Olof Bengtsson, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Lars Køber, Carolyn S.P. Lam, Felipe A. Martínez, Marc S. Sabatine, Sanjiv J. Shah, Scott D. Solomon, John J.V. McMurray - Nature Medicine 2022 cited by 275

  6. Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart Failure

    Authors: Michael R. Bristow, Leslie A. Saxon, John Boehmer, Steven K. Krueger, David A. Kass, Teresa De Marco, Peter E. Carson, Lorenzo A. DiCarlo, David L. DeMets, Bill G. White, Dale W. DeVries, Arthur M. Feldman - New England Journal of Medicine 2004 cited by 5,817

  7. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure

    Authors: Milton Packer, Michael B. Fowler, Ellen B. Roecker, Andrew J.S. Coats, Hugo A. Katus, Henry Krum, Paul Mohaçsi, Jean L. Rouleau, Michał Tendera, C Staiger, Terry L. Holcslaw, Ildikó Amann-Zalán, David L. DeMets - Circulation 2002 cited by 1,346

  8. A Trial to Evaluate the Effect of the Sodium–Glucose Co-Transporter 2 Inhibitor Dapagliflozin on Morbidity and Mortality in Patients with Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA-HF)

    Authors: John J.V. McMurray, David L. DeMets, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Felipe A. Martínez, Olof Bengtsson, Piotr Ponikowski, Marc S. Sabatine, Mikaela Sjöstrand, Scott D. Solomon - European Journal of Heart Failure 2019 cited by 447

  9. Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial

    Authors: Scott D. Solomon, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Daniel Lindholm, Ulrica Wilderäng, Fredrik Öhrn, Brian Claggett, Anna Maria Langkilde, Magnus Petersson, John J.V. McMurray - European Journal of Heart Failure 2021 cited by 322

  10. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

    Authors: Karen A. Hicks, Kenneth W. Mahaffey, Roxana Mehran, Steven E. Nissen, Stephen D. Wiviott, Billy Dunn, Scott D. Solomon, John R. Marler, John R. Teerlink, Andrew Farb, David A. Morrow, Shari Targum, Cathy A. Sila, Mary Thanh Hai, Michael R. Jaff, Hylton V. Joffe, Donald E. Cutlip, Akshay S. Desai, Eldrin F. Lewis, C. Michael Gibson, Martin Landray, A. Michael Lincoff, Christopher J. White, Steven S. Brooks, Kenneth Rosenfield, Michaël Domanski, Alexandra J. Lansky, John J.V. McMurray, James E. Tcheng, Steven R. Steinhubl, Paul Burton, Laura Mauri, Christopher M. O’Connor, Marc A. Pfeffer, Hung Hung, Norman Stockbridge, Bernard Chaitman, Robert J. Temple, Heather D. Fitter, Kachikwu Illoh, Kenneth J. Cavanaugh, Benjamin M. Scirica, Ilan Irony, Rachel E. Brown Kichline, Jonathan G. Levine, Anna Park, Leonard Sacks, Ana Szarfman, Ellis F. Unger, Lori Ann Wachter, Bram Zuckerman, Yale Mitchel, Douglas Peddicord, Thomas Shook, Bron Kisler, Charles L. Jaffe, Rhonda Bartley, David L. DeMets, MariJo Mencini, Cheri Janning, Steve Bai, John Lawrence, Ralph B. D’Agostino, Stuart Pocock - Journal of the American College of Cardiology 2018 cited by 322

  11. Effects of Dapagliflozin on Symptoms, Function, and Quality of Life in Patients With Heart Failure and Reduced Ejection Fraction

    Authors: Mikhail Kosiborod, Pardeep S. Jhund, Kieran F. Docherty, Mirta Díez, Mark C. Petrie, Subodh Verma, José Carlos Nicolau, Béla Merkely, Masafumi Kitakaze, David L. DeMets, Silvio E. Inzucchi, Lars Køber, Felipe A. Martínez, Piotr Ponikowski, Marc S. Sabatine, Scott D. Solomon, Olof Bengtsson, Daniel Lindholm, Anna Niklasson, Mikaela Sjöstrand, Anna Maria Langkilde, John J.V. McMurray - Circulation 2019 cited by 345

  12. Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction

    Authors: Scott D. Solomon, Muthiah Vaduganathan, Brian Claggett, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Jan Bělohlávek, Chern‐En Chiang, C. Jan Willem Borleffs, Josep Comín‐Colet, Dan Dobreanu, Jarosław Dróżdż, James C. Fang, Marco Antonio Alcocer Gamba, Waleed Al Habeeb, Yaling Han, Jose Walter Cabrera Honorio, Stefan Janssens, Tsvetana Katova, Masafumi Kitakaze, Béla Merkely, Eileen O’Meara, José Francisco Kerr Saraiva, Sergey Tereschenko, Jorge Thierer, Orly Vardeny, Subodh Verma, Pham Nguyễn Vinh, Ulrica Wilderäng, Natalia Zaozerska, Daniel Lindholm, Magnus Petersson, John J.V. McMurray - JACC Heart Failure 2022 cited by 165

  13. Fundamentals of Clinical Trials

    Authors: Lawrence M. Friedman, Curt D. Furberg, David L. DeMets, David M. Reboussin, Christopher B. Granger - 2015 cited by 2,240

  14. Effect of Carvedilol on Survival in Severe Chronic Heart Failure

    Authors: Milton Packer, Andrew J.S. Coats, Michael B. Fowler, Hugo A. Katus, Henry Krum, Paul Mohaçsi, Jean L. Rouleau, Michał Tendera, A Castaigne, Ellen B. Roecker, M. Schultz, C Staiger, E. Curtin, David L. DeMets - New England Journal of Medicine 2001 cited by 3,096

  15. Efficacy and Safety of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Age: The DELIVER Trial

    Authors: Alexander Peikert, Felipe A. Martínez, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Sanjiv J. Shah, Tsvetana Katova, Béla Merkely, Orly Vardeny, Ulrica Wilderäng, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon - Circulation Heart Failure 2022 cited by 124

  16. Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure

    Authors: Milton Packer, Joseph R. Carver, Richard J. Rodeheffer, Russell J. Ivanhoe, Robert DiBianco, Steven M. Zeldis, G Hendrix, William J. Bommer, Uri Elkayam, Marrick Kukin, George I. Mallis, Josephine A. Sollano, James S. Shannon, Parul Tandon, David L. DeMets - New England Journal of Medicine 1991 cited by 2,232

  17. Surrogate End Points in Clinical Trials: Are We Being Misled?

    Authors: Thomas R. Fleming, David L. DeMets - Annals of Internal Medicine 1996 cited by 1,633

  18. Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

    Authors: Orly Vardeny, James C. Fang, Akshay S. Desai, Pardeep S. Jhund, Brian Claggett, Muthiah Vaduganathan, Rudolf A. de Boer, Adrian F. Hernandez, Carolyn S.P. Lam, Silvio E. Inzucchi, Felipe A. Martínez, Mikhail Kosiborod, David L. DeMets, Eileen O’Meara, Shelley Zieroth, Josep Comín‐Colet, Jarosław Dróżdż, Chern‐En Chiang, Masafumi Kitakaze, Magnus Petersson, Daniel Lindholm, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon - Nature Medicine 2022 cited by 67

  19. Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age

    Authors: Felipe A. Martínez, Matteo Serenelli, José Carlos Nicolau, Mark C. Petrie, Chern‐En Chiang, С. Н. Терещенко, Scott D. Solomon, Silvio E. Inzucchi, Lars Køber, Mikhail Kosiborod, Piotr Ponikowski, Marc S. Sabatine, David L. DeMets, Monika Dutkiewicz-Piasecka, Olof Bengtsson, Mikaela Sjöstrand, Anna Maria Langkilde, Pardeep S. Jhund, John J.V. McMurray - Circulation 2019 cited by 207

  20. Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction

    Authors: Jonathan W. Cunningham, Muthiah Vaduganathan, Brian Claggett, Ian J. Kulac, Akshay S. Desai, Pardeep S. Jhund, Rudolf A. de Boer, David L. DeMets, Adrian F. Hernandez, Silvio E. Inzucchi, Mikhail Kosiborod, Carolyn S.P. Lam, Felipe A. Martínez, Sanjiv J. Shah, Martina M. McGrath, Eileen O’Meara, Ulrica Wilderäng, Daniel Lindholm, Magnus Petersson, Anna Maria Langkilde, John J.V. McMurray, Scott D. Solomon - Journal of the American College of Cardiology 2022 cited by 91

  21. Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients With High-risk Cardiovascular Disease

    Authors: Orly Vardeny, KyungMann Kim, Jacob A. Udell, Jacob Joseph, Akshay S. Desai, Michael E. Farkouh, Sheila M. Hegde, Adrian F. Hernandez, Allison McGeer, H. Keipp Talbot, Inder S. Anand, Deepak L. Bhatt, Christopher P. Cannon, David L. DeMets, J. Michael Gaziano, Shaun G. Goodman, Kristin L. Nichol, Matthew C. Tattersall, Jonathan L. Temte, Janet Wittes, Clyde W. Yancy, Brian Claggett, Yi Chen, Lu Mao, Thomas C. Havighurst, Lawton S. Cooper, Scott D. Solomon - JAMA 2020 cited by 129

  22. Dapagliflozin and Diuretic Use in Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HF

    Authors: Alice M. Jackson, Pooja Dewan, Inder S. Anand, Jan Bělohlávek, Olof Bengtsson, Rudolf A. de Boer, Michael Böhm, David W. Boulton, Vijay Chopra, David L. DeMets, Kieran F. Docherty, Andrej Dukát, Peter J. Greasley, Jonathan G. Howlett, Silvio E. Inzucchi, Tzvetana Katova, Lars Køber, Mikhail Kosiborod, Anna Maria Langkilde, Daniel Lindholm, Charlotta Ljungman, Felipe A. Martínez, Eileen O’Meara, Marc S. Sabatine, Mikaela Sjöstrand, Scott D. Solomon, С. Н. Терещенко, Subodh Verma, Pardeep S. Jhund, John J.V. McMurray - Circulation 2020 cited by 174

  23. Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials

    Authors: Peter Rossing, Silvio E Inzucchi, Priya Vart, Niels Jongs, Kieran F Docherty, Pardeep S Jhund, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Scott D Solomon, David L DeMets, Olof Bengtsson, Magnus Lindberg, Anna Maria Langkilde, Mikaela Sjöstrand, Bergur V Stefansson, Cecilia Karlsson, Glenn M Chertow, Fan Fan Hou, Ricardo Correa-Rotter, Robert D Toto, David C Wheeler, John J V McMurray, Hiddo J L Heerspink - The Lancet Diabetes & Endocrinology 2021 cited by 73

  24. Methods for combining randomized clinical trials: Strengths and limitations

    Authors: David L. DeMets - Statistics in Medicine 1987 cited by 1,053